Replies to post #10147 on DarioHealth Corp (DRIO)

[sandtrap246]

Agreed.

[sandtrap246]

[jimmenknee]

I'd argue the non-emotional post-RS (but fully diluted) share target based on projecting revenues in the near-term is $0.58

This assumes based on filings:
1. 31,057,233.20 shares (fully diluted)

It further assumes based on a SeeThruEquity Research Report:
2. $600,000 projected sales in Q4

It further assumes a 10x Price to Sales Ratio (PSR; it's the metric I use for OTC companies emerging from R&D into commercialization)

 
 $/year	        OS	        $/Share	        Price 	        Proj PS	Q Revs Needed 
 $1,000,000.00 	31,057,233	0.032198618	0.321986184	10	$333,333.33  
 $1,800,000.00 	31,057,233	0.057957513	0.579575131	10	$600,000.00  
 $2,000,000.00 	31,057,233	0.064397237	0.643972368	10	$666,666.67  
 $5,000,000.00 	31,057,233	0.160993092	1.609930919	10	$1,666,666.67  
 $10,000,000.00 36,297,233	0.275503093	2.755030926	10	$3,333,333.33

But I agree with you and fully expect an emotional reaction to the stock price post-RS to include continued downward drift in absence of news.

This is where momentum generation based on the vision would afford trading opportunities (and a Money Flow chart will help spot the opportunities) as a gap filler until/unless positive company fundamentals are realized